Photocure’s blue light cystoscopy demonstrates 38% recurrence reduction in BRAVO study

Photocure ASA, a bladder cancer company, has unveiled new clinical evidence demonstrating the advantages of blue light cystoscopy (BLC) over traditional white light cystoscopy (WLC) in reducing bladder cancer recurrence. The findings, published in JU Open Plus, come from the BRAVO study (Bladder Cancer Recurrence Analysis in Veterans and Outcomes), a real-world, propensity-score-matched anal